{"id":"W4281670642","doi":"10.1200/jco.2022.40.16_suppl.9016","title":"Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met–overexpressing (OE) advanced non-small cell lung cancer (NSCLC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Immunohistochemistry; Cohort; Interim analysis; Oncology; Stage (stratigraphy); Clinical endpoint; Cancer; Lung cancer; Interim; Chemotherapy; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007677994,0.0002229928,0.001295626,0.0002117913,0.0001221203,0.00001450027,0.0001940488,0.0001599044,0.000346669],"category_scores_gemma":[0.0001371601,0.0001573948,0.0002899366,0.0003104385,0.00007698787,0.0001541321,0.0000562655,0.001038253,0.000002653103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001348891,"about_ca_system_score_gemma":0.003153681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002548838,"about_ca_topic_score_gemma":0.0001110633,"domain_scores_codex":[0.9968156,0.0003664817,0.001746108,0.0003185665,0.0003937461,0.0003594577],"domain_scores_gemma":[0.9968876,0.0005403623,0.001723573,0.0002314706,0.0003271253,0.0002898439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01225898,0.005314028,0.7683004,0.00006213078,0.0005346798,0.000357181,0.001150572,0.002832654,0.0001767418,0.000002571908,0.001829886,0.2071802],"study_design_scores_gemma":[0.1394605,0.05423244,0.7064183,0.0009534655,0.001943176,0.00008920941,0.0009823831,0.0007478973,0.0003628861,0.00003549345,0.09432333,0.0004508908],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920986,0.002883422,0.00009303816,0.0007382252,0.0006767169,0.0008396223,0.0000188701,0.00001348877,0.002638021],"genre_scores_gemma":[0.9917909,0.001162413,0.00387146,0.002150547,0.0002974342,0.0001021626,0.00001854013,0.00005000117,0.0005565608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2067294,"threshold_uncertainty_score":0.6418372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03010467439627324,"score_gpt":0.4231097895866135,"score_spread":0.3930051151903403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}